PROCYON CORPORATION (OTCMKTS:PCYN) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment ofCertain Officers; Compensatory Arrangements of Certain Officers.

(b) Regina W. Anderson resigned her positions as Procyon Corporation’s (the “Corporation”) ChiefExecutive Officer and President on January 9, 2018. The Corporation’s Board of Directors voted to

have Ms. Anderson continue as Chairman of the Board. The Corporation is in the process of preparing a written amendment to Ms. Anderson’s employment agreement.

Also on January 9, 2018, Justice W. Anderson resigned from his position as Vice President ofSales of the Corporation.

(c) The Corporation’s Board of Directors elected Justice W. Anderson Chief Executive Officer and President of the Corporation on January 9, 2018, while retaining his current position as President of Amerx Health Care Corporation, the Corporation’s subsidiary. Justice Anderson’s former position as Vice President of Sales of the Corporation will remain unfilled. The Corporation is in the process of preparing a written amendment to Ms. Anderson’s employment agreement.

Mr. Anderson’s age, business experience and family relationships with other executive officers has been previously disclosed, most recently in the Corporation’s Proxy Statement filed with the Securities and Exchange Commission on or about October 11, 2017. The Corporation and Mr. Anderson have agreed that Mr. Anderson’s compensation will remain the same for the period of his most recent Amended Executive Employment Agreement, which was previously disclosed.

Item 5.07 Submission of Matters to a Vote of Security Holders

We held our annual meeting for fiscal 2018 on Tuesday, November 14, 2017, at 4:00 p.m. EST. The following matters were considered and approved by the shareholders:

The following seven directors were elected to hold office for one-year terms or until their successors are elected and qualified:

to the following vote, the appointment of Ferlita, Walsh, Gonzalez and Rodriguez, P.A. as our independent certified public accountants for the 2018 fiscal year, was ratified:

About PROCYON CORPORATION (OTCMKTS:PCYN)

Procyon Corporation (Procyon) operates through its subsidiary, Amerx Health Care Corporation (Amerx). Amerx develops and markets medical products used in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation and other skin problems. Its product lines include AMERX, AMERIGEL and HELIX3 Bioactive Collagen. Amerx markets a line of AMERIGEL skin and wound care products made with Oakin that promotes healing in wound and problematic skin conditions, including the AMERIGEL Hydrogel Wound Dressing, AMERIGEL Hydrogel Gauze Dressing, AMERIGEL Saline Wound Wash, AMERIGEL Care Lotion and AMERIGEL Barrier Lotion. HELIX3 is available in two forms: Collagen Powder (HELIX3 CP) and Collagen Matrix (HELIX3 CM). Its wound care product line consists of AMERX Calcium Alginate Dressing, AMERX Foam Dressing, AMERX Gauze Dressing, AMERX Hydrocolloid Dressing and Amerx Wound Care Kits.